Amlodipine
آملودیپین
❤️ Cardiovascular SystemCalcium channel blocker
Market / country: 🇺🇸 USA
Norvasc (US)
🧮 Dose calculator
Hypertension · Regimen source: FDA Amlodipine · 2.2FDA Amlodipine · 8.4
- • Doses above 5 mg not studied in children. FDA Amlodipine · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Known sensitivity to amlodipine. FDA Amlodipine · 4
Formulations
- 5 mg tablet — tablet 🇺🇸 USA FDA Amlodipine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Amlodipine · 8.1
“Risk Summary The limited available data based on post-marketing reports with amlodipine use in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Amlodipine · 8.2
“Risk Summary Limited available data from a published clinical lactation study reports that amlodipine is present in human milk at an estimated median relative infant dose of 4.2%.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Amlodipine · 8.4
“Amlodipine besylate tablets (2.5 to 5 mg daily) is effective in lowering blood pressure in patients 6 to 17 years [see Clinical Studies (14.1) ] .”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Amlodipine · 8.5
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA078925
- DailyMed (FDA label)FDA Amlodipine
- MedlinePlus (NIH)Amlodipine
- WHO ATC/DDDC08CA01
- Darooyab (Iran)Amlodipine
🇮🇷 Registered in Iran Darooyab · G-1522/Amlodipine
Dosage forms with Iranian generic codes, per Darooyab.
- 10691 · AMLODIPINE 10MG TAB · قرص آملودیپین ۱۰ میلیگرم
- 10665 · AMLODIPINE 2.5MG TAB · قرص آملودیپین ۲٫۵ میلیگرم
- 00070 · AMLODIPINE 5MG TAB · قرص آملودیپین ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Amlodipine · 3FDA Amlodipine · 2.2FDA Amlodipine · 8.4FDA Amlodipine · 2.1FDA Amlodipine · 4FDA Amlodipine · 8.1FDA Amlodipine · 8.2FDA Amlodipine · 8.5FDA Amlodipine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1522/Amlodipine
- Clinical review⚠ Unverified